We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA expects sponsors of breast cancer trials to include men as well as women and the scarcity of men with the condition is not an acceptable reason for excluding them from a trial, according to a new final guidance from the FDA. Read More
Mexico’s drug regulators have approved RedHill Biopharma’s planned phase 2/3 trial of Yeliva (opaganib) in hospitalized COVID-19 patients with pneumonia. Read More
Vir Biotechnology plans to launch a phase 2/3 trial this month of VIR-7831, a neutralizing monoclonal antibody for the treatment of COVID-19 patients. Read More
Mexico has agreed to host several phase 3 clinical trials of potential COVID-19 vaccines as the pace of research worldwide continues to gain momentum. Read More
Russia has approved the world’s first coronavirus vaccine, President Vladimir Putin announced Tuesday, prompting widespread concerns about the vaccine’s safety as it is only entering a late-stage clinical trial this week. Read More
China-based CanSino Biologics is preparing a phase 3 trial of its COVID-19 vaccine in Saudi Arabia, the country’s Ministry of Health has announced. Read More
Pfizer’s CEO Albert Bourla said that it is “highly likely” that the ongoing phase 3 trial of its mRNA-based COVID-19 vaccine candidate, BNT162, will show in October whether the vaccine is safe and effective — and said the company plans to seek the FDA’s approval the same month if the data support it. Read More